The M6A Methyltransferase METTL3 Drives Thyroid Cancer Progression and Lymph Node Metastasis by Targeting LINC00894

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2024 Jan 30

PMID 38291427

Authors

Xiang Zhou

Lisha Chang

Qiaoqiao Liang

Rongjie Zhao

Yong Xiao

Zheng Xu

Leitao Yu

Affiliations

Soon will be listed here.

Abstract

Background: Long noncoding RNAs (lncRNAs) are significant contributors to various human malignancies. The aberrant expression of lncRNA LINC00894 has been reported in various human malignancies. We aimed to illustrate the role of LINC00894 and its underlying mechanism in the development of papillary thyroid carcinoma (PTC).

Methods: We performed bioinformatics analysis of differentially expressed RNAs from TCGA and GEO datasets and selected the target lncRNA LINC00894. SRAMP analysis revealed abundant M6A modification sites in LINC00894. Further analysis of StarBase, GEPIA, and TCGA datasets was performed to identify the related differentially expressed genes METTL3. Colony formation and CCK-8 assays confirmed the relationship between LINC00894, METTL3, and the proliferative capacity of PTC cells. The analysis of AnnoLnc2, Starbase datasets, and meRIP-PCR and qRT‒PCR experiments confirmed the influence of METTL3-mediated m6A modification on LINC00894. The study employed KEGG enrichment analysis as well as Western blotting to investigate the impact of LINC00894 on the expression of proteins related to the Hippo signalling pathway.

Results: LINC00894 downregulation was detected in PTC tissues and cells and was even further downregulated in PTC with lymphatic metastasis. LINC00894 inhibits the lymphangiogenesis of vascular endothelial cells and the proliferation of cancer cells. METTL3 enhances PTC progression by upregulating LINC00894 by enhancing LINC00894 mRNA stability through the m6A-YTHDC2-dependent pathway. LINC00894 may inhibit PTC malignant phenotypes through the Hippo signalling pathway.

Conclusion: The METTL3-YTHDC2 axis stabilizes LINC00894 mRNA in an m6A-dependent manner and subsequently inhibits tumour malignancy through the Hippo signalling pathway.

Citing Articles

Integration of 101 machine learning algorithm combinations to unveil m6A/m1A/m5C/m7G-associated prognostic signature in colorectal cancer.

Wei H, Luo Q, Zhong W Sci Rep. 2025; 15(1):5930.

PMID: 39966486 PMC: 11836460. DOI: 10.1038/s41598-025-89944-8.

Effects of I and TSH suppression therapy on METTL3, METTL14 levels and recurrence in thyroid cancer.

Yang L, Yang Z, Zhang J, Fu Y Am J Cancer Res. 2025; 15(1):42-58.

PMID: 39949928 PMC: 11815380. DOI: 10.62347/THJB4749.

Development of animal models to study aggressive thyroid cancers.

Dutta S, Knauf J Eur Thyroid J. 2025; 14(1).

PMID: 39874138 PMC: 11825169. DOI: 10.1530/ETJ-24-0361.

The role of epigenetic methylations in thyroid Cancer.

Yu X, Zhang H, Zhang H, Hou C, Wang X, Gu P World J Surg Oncol. 2024; 22(1):281.

PMID: 39456011 PMC: 11515417. DOI: 10.1186/s12957-024-03568-2.

Role of N6-methyladenosine methylation in head and neck cancer and its regulation of innate immune pathways.

Cao L, Huang G, Fan J, Liu X, Ma Z Front Immunol. 2024; 15:1458884.

PMID: 39403369 PMC: 11471572. DOI: 10.3389/fimmu.2024.1458884.

References

Liu X, Zhang C, Wang X, Cui C, Cui H, Zhu B . Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer. Endocr Relat Cancer. 2023; 30(3). PMC: 9986400. DOI: 10.1530/ERC-22-0221. View

Song H, Qiu Z, Wang Y, Xi C, Zhang G, Sun Z . HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression. Int J Biol Sci. 2023; 19(1):225-241. PMC: 9760428. DOI: 10.7150/ijbs.75459. View

Isin M, Ozgur E, Cetin G, Erten N, Aktan M, Gezer U . Investigation of circulating lncRNAs in B-cell neoplasms. Clin Chim Acta. 2014; 431:255-9. DOI: 10.1016/j.cca.2014.02.010. View

Wang J, Tan L, Jia B, Yu X, Yao R, Ouyang N . Downregulation of mA Reader YTHDC2 Promotes the Proliferation and Migration of Malignant Lung Cells via CYLD/NF-κB Pathway. Int J Biol Sci. 2021; 17(10):2633-2651. PMC: 8315025. DOI: 10.7150/ijbs.58514. View

Meng D, Shao H, Feng C . LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression. Onco Targets Ther. 2021; 14:3395-3407. PMC: 8164724. DOI: 10.2147/OTT.S277284. View

Reis E, Verjovski-Almeida S . Perspectives of Long Non-Coding RNAs in Cancer Diagnostics. Front Genet. 2012; 3:32. PMC: 3297063. DOI: 10.3389/fgene.2012.00032. View

Wang X, Feng J, Xue Y, Guan Z, Zhang D, Liu Z . Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature. 2016; 534(7608):575-8. DOI: 10.1038/nature18298. View

Ying Y, Ma X, Fang J, Chen S, Wang W, Li J . EGR2-mediated regulation of mA reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization. Cell Death Dis. 2021; 12(8):750. PMC: 8322060. DOI: 10.1038/s41419-021-04038-3. View

Chen B, Liu D, Chen R, Guo L, Ran J . Elevated LINC00894 relieves the oncogenic properties of thyroid cancer cell by sponging let-7e-5p to promote TIA-1 expression. Discov Oncol. 2022; 13(1):56. PMC: 9249958. DOI: 10.1007/s12672-022-00520-2. View

10.

Zhou Q, Li D, Zheng H, He Z, Qian F, Wu X . A novel lncRNA-miRNA-mRNA competing endogenous RNA regulatory network in lung adenocarcinoma and kidney renal papillary cell carcinoma. Thorac Cancer. 2021; 12(19):2526-2536. PMC: 8487820. DOI: 10.1111/1759-7714.14129. View

11.

Hsu P, Zhu Y, Ma H, Guo Y, Shi X, Liu Y . Ythdc2 is an N-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017; 27(9):1115-1127. PMC: 5587856. DOI: 10.1038/cr.2017.99. View

12.

Yan C, Yang H, Su P, Li X, Li Z, Wang D . OTUB1 suppresses Hippo signaling via modulating YAP protein in gastric cancer. Oncogene. 2022; 41(48):5186-5198. PMC: 9700521. DOI: 10.1038/s41388-022-02507-3. View

13.

Vaccarella S, Franceschi S, Bray F, Wild C, Plummer M, Dal Maso L . Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med. 2016; 375(7):614-7. DOI: 10.1056/NEJMp1604412. View

14.

Chen H, Pan Y, Zhou Q, Liang C, Wong C, Zhou Y . METTL3 Inhibits Antitumor Immunity by Targeting mA-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer. Gastroenterology. 2022; 163(4):891-907. DOI: 10.1053/j.gastro.2022.06.024. View

15.

Liao L, He Y, Li S, Zhang G, Yu W, Yang J . Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3. Cancer Res. 2022; 82(13):2444-2457. DOI: 10.1158/0008-5472.CAN-21-4124. View

16.

Xiao J, Bing Z, Xiao G, Guan Y, Luan J . Long non-coding (lnc)RNA PAPAS overexpression inhibits tumor growth in papillary thyroid carcinoma by downregulating lncRNA HOTTIP. Oncol Lett. 2020; 19(3):2281-2285. PMC: 7039133. DOI: 10.3892/ol.2020.11323. View

17.

Li Y, He X, Lu X, Gong Z, Li Q, Zhang L . METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. Nat Commun. 2022; 13(1):6350. PMC: 9605963. DOI: 10.1038/s41467-022-34209-5. View

18.

Lei T, He D, Cao J, Lv W . CircWDR26 regulates endometrial carcinoma progression via miR-212-3p-mediated typing genes MSH2. Eur J Med Res. 2022; 27(1):135. PMC: 9327368. DOI: 10.1186/s40001-022-00755-3. View

19.

Zhu Y, Peng X, Zhou Q, Tan L, Zhang C, Lin S . METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Cell Death Dis. 2022; 13(4):358. PMC: 9016063. DOI: 10.1038/s41419-022-04817-6. View

20.

Thompson B, Cohen S . The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell. 2006; 126(4):767-74. DOI: 10.1016/j.cell.2006.07.013. View